GJA1 and epilepsy: In contrast, recent neuropsychopharmacological studies have indicated the possibility that regulation of astroglial Cx43-containing hemichannels could be novel targets for several neuropsychiatric disorders, such as bipolar disorder, schizophrenia, epilepsy, autism spectrum disorder and their associated cognitive impairment [22,32,33].